<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39266812</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1179-1942</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>Drug safety</Title><ISOAbbreviation>Drug Saf</ISOAbbreviation></Journal><ArticleTitle>Qualitative Interviews with Stakeholders in Herbal Pharmacovigilance and Recommendations for Best Practices to be Applied Worldwide.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40264-024-01480-y</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVE" NlmCategory="OBJECTIVE">The use of herbal products globally is substantial, but varying definitions and regulatory frameworks have led to differences in their status as medicinal products and in approaches to monitoring their safety. This article explores the current landscape of herbal pharmacovigilance, drawing insights from interviews with global experts in the field, and offers recommendations for best practices to enhance the safety and benefit-to-harm balance of herbal products.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This study comprised semi-structured interviews with members of the International Society of Pharmacovigilance-Herbal and Traditional Medicines Special Interest Group and the Nutrivigilance Information Exchange Network, recruited using purposive sampling. Data were stored and coded using NVIVO<sup>®</sup> and analysed thematically using a qualitative inductive approach.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Sixteen participants from 11 countries were interviewed, revealing diverse regulatory approaches and challenges in herbal pharmacovigilance. Key themes included legal status, awareness, identification and coding of herbal products, pre-/post-marketing product control, reporting of adverse drug reactions, causality assessment and signals of herbal products. This study yielded five general recommendations to further improve herbal pharmacovigilance worldwide.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study offers an overview of the global landscape of herbal pharmacovigilance, highlighting challenges in monitoring herbal products and presenting universal recommendations. These recommendations encompass increasing awareness, enhancing education and improving legislative frameworks. Given the growing use of herbal products, the implementation of strong pharmacovigilance practices is crucial to ensure consumer safety.</AbstractText><CopyrightInformation>© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ekhart</LastName><ForeName>Corine</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-2252-0467</Identifier><AffiliationInfo><Affiliation>Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH's, Hertogenbosch, The Netherlands. c.ekhart@lareb.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiarda</LastName><ForeName>Sjoerd H P</ForeName><Initials>SHP</Initials><AffiliationInfo><Affiliation>Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH's, Hertogenbosch, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmaceutical Technology and Biopharmacy, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van de Koppel</LastName><ForeName>Sonja</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH's, Hertogenbosch, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skalli</LastName><ForeName>Souad</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Science Mohammed V University, Rabat, Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alghamdi</LastName><ForeName>Waad</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Pharmacovigilance Directorate, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menniti-Ippolito</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Italian National Institute of Health, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tangchitkhachon</LastName><ForeName>Kunwarang</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Praboromarajchanok Institute Ministry of Public Health, Nonthaburi, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mponda</LastName><ForeName>John Samson</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Pharmacy Department, Kamuzu University of Health Sciences, Blantyre, Malawi.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Africa Centre of Excellence in Public Health and Herbal Medicine, Kamuzu University of Health Sciences, Blantyre, Malawi.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woerdenbag</LastName><ForeName>Herman J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Technology and Biopharmacy, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Hunsel</LastName><ForeName>Florence</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH's, Hertogenbosch, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of PharmacoTherapy, Epidemiology &amp; Economics, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Drug Saf</MedlineTA><NlmUniqueID>9002928</NlmUniqueID><ISSNLinking>0114-5916</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>0</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>0</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>12</Day><Hour>23</Hour><Minute>36</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39266812</ArticleId><ArticleId IdType="doi">10.1007/s40264-024-01480-y</ArticleId><ArticleId IdType="pii">10.1007/s40264-024-01480-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Thakkar S, Anklam E, Xu A, Ulberth F, Li J, Li B, et al. Regulatory landscape of dietary supplements and herbal medicines from a global perspective. Regul Toxicol Pharmacol. 2020;114: 104647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yrtph.2020.104647</ArticleId><ArticleId IdType="pubmed">32305367</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems. Updated 2004. https://apps.who.int/iris/bitstream/handle/10665/43034/9241592214_eng.pdf . Accessed 5 Sep 2024.</Citation></Reference><Reference><Citation>Directive 2004/24/EC of the European Parliament and of the Council. https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2004:136:0085:0090:en:PDF . Accessed 5 Sep 2024.</Citation></Reference><Reference><Citation>Frye JC. Herbal and homeopathic medicine: understanding the difference. Semin Integr Med. 2003;1(3):158–66.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1543-1150(03)00030-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes J. Pharmacovigilance of herbal medicines : a UK perspective. Drug Saf. 2003;26(12):829–51.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00002018-200326120-00001</ArticleId><ArticleId IdType="pubmed">12959628</ArticleId></ArticleIdList></Reference><Reference><Citation>European Medicines Agency. Herbal medicinal products. https://www.ema.europa.eu/en/human-regulatory-overview/herbal-medicinal-products . Accessed 5 Sep 2024.</Citation></Reference><Reference><Citation>van Hunsel F, van der Kooi D, van de Koppel S, Kroes BH, Woerdenbag HJ. Analysis of reports on adverse drug reactions related to herbal medicinal products and herbal supplements in the Netherlands received by the National Pharmacovigilance Centre Lareb. Drug Saf. 2022;45(6):651–61.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-022-01180-5</ArticleId><ArticleId IdType="pubmed">35608783</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes J. Pharmacovigilance for herbal and traditional medicines. Cham: Adis International Ltd.; 2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-031-07275-8</ArticleId></ArticleIdList></Reference><Reference><Citation>European Medicines Agency. Pharmacovigilance: overview. https://www.ema.europa.eu/en/human-regulatory/overview/pharmacovigilance-overview . Accessed 5 Sep 2024.</Citation></Reference><Reference><Citation>Rodrigues E, Barnes J. Pharmacovigilance of herbal medicines: the potential contributions of ethnobotanical and ethnopharmacological studies. Drug Saf. 2013;36(1):1–12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-012-0005-7</ArticleId><ArticleId IdType="pubmed">23315291</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw D, Graeme L, Pierre D, Elizabeth W, Kelvin C. Pharmacovigilance of herbal medicine. J Ethnopharmacol. 2012;140(3):513–8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2012.01.051</ArticleId><ArticleId IdType="pubmed">22342381</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2014;4:177.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2013.00177</ArticleId><ArticleId IdType="pubmed">24454289</ArticleId><ArticleId IdType="pmc">3887317</ArticleId></ArticleIdList></Reference><Reference><Citation>Walji R, Boon H, Barnes J, Austin Z, Baker GR, Welsh S. Adverse event reporting for herbal medicines: a result of market forces. Healthc Policy. 2009;4(4):77–90.</Citation><ArticleIdList><ArticleId IdType="pubmed">20436811</ArticleId><ArticleId IdType="pmc">2700706</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas DR. A general inductive approach for analyzing qualitative evaluation data. Am J Eval. 2006;27(2):237–46.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1098214005283748</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell S, Greenwood M, Prior S, Shearer T, Walkem K, Young S, et al. Purposive sampling: complex or simple? Research case examples. J Res Nurs. 2020;25(8):652–61.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1744987120927206</ArticleId><ArticleId IdType="pubmed">34394687</ArticleId><ArticleId IdType="pmc">7932468</ArticleId></ArticleIdList></Reference><Reference><Citation>Klerings I, Robalino S, Booth A, Escobar-Liquitay CM, Sommer I, Gartlehner G, et al. Rapid reviews methods series: guidance on literature search. BMJ Evid Based Med. 2023;28(6):412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjebm-2022-112079</ArticleId><ArticleId IdType="pubmed">37076268</ArticleId><ArticleId IdType="pmc">10715472</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiarda S. Best practices of pharmacovigilance of herbal medicinal products. University of Groningen; 2022. https://fse.studenttheses.ub.rug.nl/27285/ . Accessed 5 Sep 2024.</Citation></Reference><Reference><Citation>International Society of Pharmacovigilance. Special interest groups: herbal and traditional medicines group. https://isoponline.org/special-interest-groups/herbal-and-traditional-medicines-2/ . Accessed 5 Sep 2024.</Citation></Reference><Reference><Citation>ANSES. Nutrivigilance. https://www.anses.fr/fr/content/tout-savoir-sur-le-dispositif-de-nutrivigilance . Accessed 5 Sep 2024.</Citation></Reference><Reference><Citation>Crouse T, Lowe PA. The SAGE encyclopedia of educational research, measurement, and evaluation. Thousand Oaks (CA): SAGE Publications, Inc.; 2018. https://sk.sagepub.com/reference/sage-encyclopedia-of-educational-research-measurement-evaluation . Accessed 5 Sep 2024.</Citation></Reference><Reference><Citation>Kirchherr J, Charles K. Enhancing the sample diversity of snowball samples: recommendations from a research project on anti-dam movements in Southeast Asia. PLoS ONE. 2018;13(8): e0201710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0201710</ArticleId><ArticleId IdType="pubmed">30133457</ArticleId><ArticleId IdType="pmc">6104950</ArticleId></ArticleIdList></Reference><Reference><Citation>Glaser B, Strauss A. Discovery of grounded theory: strategies for qualitative research (1st ed.). Routledge. 1999. https://doi.org/10.4324/9780203793206</Citation></Reference><Reference><Citation>Guest G, Namey E, Chen M. A simple method to assess and report thematic saturation in qualitative research. PLoS ONE. 2020;15(5): e0232076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0232076</ArticleId><ArticleId IdType="pubmed">32369511</ArticleId><ArticleId IdType="pmc">7200005</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennink MM, Kaiser BN. Saturation in qualitative research. London. 2019. https://methods-sagepub-com-christuniversity.knimbus.com/foundations/saturation-in-qualitative-research . Accessed 5 Sep 2024.</Citation></Reference><Reference><Citation>Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/1478088706qp063oa</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundler AJ, Lindberg E, Nilsson C, Palmér L. Qualitative thematic analysis based on descriptive phenomenology. Nurs Open. 2019;6(3):733–9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nop2.275</ArticleId><ArticleId IdType="pubmed">31367394</ArticleId><ArticleId IdType="pmc">6650661</ArticleId></ArticleIdList></Reference><Reference><Citation>NVivo. https://www.nvivo.nl/ . Accessed 5 Sep 2024.</Citation></Reference><Reference><Citation>AlYahmady HH, Alabri SS. Using Nvivo for data analysis in qualitative research. Int Interdiscip J Educ. 2013;2:181–6.</Citation></Reference><Reference><Citation>Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–57.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intqhc/mzm042</ArticleId><ArticleId IdType="pubmed">17872937</ArticleId></ArticleIdList></Reference><Reference><Citation>Alghamdi W, Al-Fadel N, Alghamdi EA, Alghamdi M, Alharbi F. Signal detection and assessment of herb-drug interactions: Saudi Food and Drug Authority experience. Drugs Real World Outcomes. 2023;10(4):577–85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40801-023-00388-w</ArticleId><ArticleId IdType="pubmed">37857794</ArticleId><ArticleId IdType="pmc">10730488</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan LM, Al-Harthi SE, Osman AM, Sattar MA, Ali AS. Dilemmas of the causality assessment tools in the diagnosis of adverse drug reactions. Saudi Pharm J. 2016;24(4):485–93.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsps.2015.01.010</ArticleId><ArticleId IdType="pubmed">27330379</ArticleId></ArticleIdList></Reference><Reference><Citation>European Medicines Agency. Signal management. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/pharmacovigilance-post-authorisation/signal-management . Accessed 5 Sep 2024.</Citation></Reference><Reference><Citation>Biagi M, Pecorari R, Appendino G, Miraldi E, Magnano AR, Governa P, et al. Herbal products in Italy: the thin line between phytotherapy, nutrition and parapharmaceuticals; a normative overview of the fastest growing market in Europe. Pharmaceuticals (Basel). 2016;9(4):65.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph9040065</ArticleId><ArticleId IdType="pubmed">27801865</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer A, Geboers L, van de Koppel S, van Hunsel F. Governance of nutrivigilance in the Netherlands: reporting adverse events of non-registered products. Health Policy. 2022;126(8):731–7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healthpol.2022.05.011</ArticleId><ArticleId IdType="pubmed">35643570</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouveia BG, Rijo P, Gonçalo TS, Reis CP. Good manufacturing practices for medicinal products for human use. J Pharm Bioallied Sci. 2015;7(2):87–96.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0975-7406.154424</ArticleId><ArticleId IdType="pubmed">25883511</ArticleId><ArticleId IdType="pmc">4399016</ArticleId></ArticleIdList></Reference><Reference><Citation>Duraz AY, Khan SA. Knowledge, attitudes and awareness of community pharmacists towards the use of herbal medicines in muscat region. Oman Med J. 2011;26(6):451–3.</Citation><ArticleIdList><ArticleId IdType="doi">10.5001/omj.2011.115</ArticleId><ArticleId IdType="pubmed">22253959</ArticleId><ArticleId IdType="pmc">3251205</ArticleId></ArticleIdList></Reference><Reference><Citation>Worakunphanich W, Suwankesawong W, Youngkong S, Thavorncharoensap M, Anderson C, Toh LS. Thai stakeholders’ awareness and perceptions of the patient adverse event reporting system for herbal medicines: a qualitative study. Int J Clin Pharm. 2023;45(2):491–501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11096-022-01533-1</ArticleId><ArticleId IdType="pubmed">36745312</ArticleId><ArticleId IdType="pmc">9901401</ArticleId></ArticleIdList></Reference><Reference><Citation>Menniti-Ippolito F, Mazzanti G, Santuccio C, Moro PA, Calapai G, Firenzuoli F, et al. Surveillance of suspected adverse reactions to natural health products in Italy. Pharmacoepidemiol Drug Saf. 2008;17(6):626–35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.1566</ArticleId><ArticleId IdType="pubmed">18327867</ArticleId></ArticleIdList></Reference><Reference><Citation>Skalli S. The Moroccan experience of implementing a university curriculum for the pharmacovigilance of herbal medicines (phytovigilance). Drug Saf. 2024;47(3):285–6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-023-01372-7</ArticleId><ArticleId IdType="pubmed">37966695</ArticleId></ArticleIdList></Reference><Reference><Citation>Mponda J, Muula A, Choko A, Ajuwon A, Moody J. Consumption and adverse reaction reporting of herbal medicines among people living with HIV at university teaching hospitals in Blantyre, Malawi and Ibadan, Nigeria. Malawi Med J. 2024;36:13–22.</Citation><ArticleIdList><ArticleId IdType="doi">10.4314/mmj.v36i1.3</ArticleId><ArticleId IdType="pubmed">39086363</ArticleId><ArticleId IdType="pmc">11287810</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury A, Singh PA, Bajwa N, Dash S, Bisht P. Pharmacovigilance of herbal medicines: concerns and future prospects. J Ethnopharmacol. 2023;309: 116383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2023.116383</ArticleId><ArticleId IdType="pubmed">36918049</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiguba R, Olsson S, Waitt C. Pharmacovigilance in low- and middle-income countries: a review with particular focus on Africa. Br J Clin Pharmacol. 2023;89(2):491–509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bcp.15193</ArticleId><ArticleId IdType="pubmed">34937122</ArticleId></ArticleIdList></Reference><Reference><Citation>Saokaew S, Suwankesawong W, Permsuwan U, Chaiyakunapruk N. Safety of herbal products in Thailand: an analysis of reports in the thai health product vigilance center database from 2000 to 2008. Drug Saf. 2011;34(4):339–50.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/11586590-000000000-00000</ArticleId><ArticleId IdType="pubmed">21417506</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal, SC, Chakraborty R, Sen S (2021) Evidence based validation of traditional medicines: a comprehensive approach. https://doi.org/10.1007/978-981-15-8127-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-15-8127-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Menniti-Ippolito F, Aiello E, Arzenton E, Assisi A, Blaznik U, Castenmiller JJM, et al. Erice Manifesto 2022: on the surveillance of potential harms caused by food supplements in Europe. Drug Saf. 2023;46(5):435–7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-023-01284-6</ArticleId><ArticleId IdType="pubmed">37022637</ArticleId></ArticleIdList></Reference><Reference><Citation>Vo Van Regnault G, Costa MC, Adanić Pajić A, Bico AP, Bischofova S, Blaznik U, et al. The need for European harmonization of Nutrivigilance in a public health perspective: a comprehensive review. Crit Rev Food Sci Nutr. 2022;62(29):8230–46.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408398.2021.1926904</ArticleId><ArticleId IdType="pubmed">34036844</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters T, Soanes N, Abbas M, Ahmad J, Delumeau JC, Herrero-Martinez E, et al. Effective pharmacovigilance system development: EFPIA-IPVG Consensus recommendations. Drug Saf. 2021;44(1):17–28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-020-01008-0</ArticleId><ArticleId IdType="pubmed">33289904</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasileiou K, Barnett J, Thorpe S, Young T. Characterising and justifying sample size sufficiency in interview-based studies: systematic analysis of qualitative health research over a 15-year period. BMC Med Res Methodol. 2018;18(1):148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-018-0594-7</ArticleId><ArticleId IdType="pubmed">30463515</ArticleId><ArticleId IdType="pmc">6249736</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennink M, Kaiser BN. Sample sizes for saturation in qualitative research: a systematic review of empirical tests. Soc Sci Med. 2022;292: 114523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2021.114523</ArticleId><ArticleId IdType="pubmed">34785096</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>